Teva new CEO Kare Schultz
Teva (TEVA) has had some exciting news to present over the past week. It hired 30-year industry veteran Kare Schultz as its full-time CEO. He will be charged with rightsizing the business while simultaneously paring debt. To that end, the company completed the $1.1 billion sale of its Paragard intrauterine copper contraceptive to CooperSurgical: